Opened our 5th
clinic in Asia

15.09.22

Bali

Total domestic
stimulated cycles

↓ 0.3%

On FY21 (FY22; 9,783)

New patient domestic
stimulated cycles

↑ 2.2%

On FY21 (FY22; 4,881)

New Patient Registrations
increased by

↑ 4.0%

 compared to FY21

Domestic
acquisitions

2

 

Total embryos
screened (PGT)

↑ 14.7%

On FY21 (FY22, 5,487)

Success rates
increased by

↑ 4.4%

Since 2018

Employee Engagement
Culture of Success

61%

 

Average patient
NPS score

+66

 

31 New Domestic and International Fertility Specialists

joined Monash IVF Group in July 2021-August 2022 through recruitment, acquisitions and our internal training program.

Revenue

$192.3m

↑ 4.7% on FY21

Underlying NPAT1,3

$22.2m

↓ 4.7% on FY21

Underlying EBITDA1

$48.1m

↑ 0.8% on FY21

Underlying EBIT1

$33.4m

↓ 5.0% on FY21

Reported NPAT3

$18.5m

↓ 28.0% on FY21

1. Non-IFRS measure
2. Refer to reconciliation of Reported EBITDA, EBIT and NPAT to Adjusted EBITDA, EBIT and NPAT
3. NPAT including minority interest